iarc newsletter
Donate now

Cancer Surveillance Branch (CSU)



  1. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. (2023). Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 72(2):338–44. https://doi.org/10.1136/gutjnl-2022-327736 PMID:36604116
  2. Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, et al.; SURVCAN-3 collaborators (2023). Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncol. 24(1):22–32. https://doi.org/10.1016/S1470-2045(22)00704-5 PMID:36603919
  3. Cabasag CJ, Arnold M, Rutherford M, Ferlay J, Bardot A, Morgan E, et al. (2022). Shifting incidence and survival of epithelial ovarian cancer (1995-2014): a SurvMark-2 study. Int J Cancer. 34403. https://doi.org/10.1002/ijc.34403 PMID:36533660
  4. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2022 Dec 14:S2214-109X(22)00501-0. https://doi.org/10.1016/S2214-109X(22)00501-0 PMID: 36528031
  5. Cabasag CJ, Vignat J, Ferlay J, Arndt V, Lemmens V, Praagman J, et al. (2022). The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020. Eur J Cancer. 177:15–24. https://doi.org/10.1016/j.ejca.2022.09.030 PMID:36323048
  6. Piñeros M, Laversanne M, Barrios E, Cancela MC, de Vries E, Pardo C, et al. (2022). An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health Am. 13(Sep): https://doi.org/10.1016/j.lana.2022.100294 PMID:36189115
  7. Piñeros M, Ginsburg O, Bendahhou K, Eser S, Shelpai WA, Fouad H, et al.; Staging Survey Group (2022). Staging practices and breast cancer stage among population-based registries in the MENA region. Cancer Epidemiol. 81:102250. https://doi.org/10.1016/j.canep.2022.102250 PMID:36115143
  8. Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. (2022). The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 163(3):649–e2. https://doi.org/10.1053/j.gastro.2022.05.054 PMID:35671803
  9. Ilbawi AM, Lam CG, Ortiz R, Bray F (2022). Investing in childhood cancer registries to drive progress. Lancet Child Adolesc Health. 6(7):446–7. https://doi.org/10.1016/S2352-4642(22)00148-1 PMID:35605627
  10. Bray F, Parkin DM, Gnangnon F, Tshisimogo G, Peko J-F, Adoubi I, et al.; African Cancer Registry Network (2022). Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol. 23(6):719–28. https://doi.org/10.1016/S1470-2045(22)00270-4 PMID:35550275
  11. Znaor A, Corbex M, Cao B, Laversanne M, Ryzhov A, Smelov V, et al. (2022). Progress in reducing premature mortality from cancer and cardiovascular disease in the former Soviet Union, 2000-19. Eur J Public Health. 32(4):624–9. https://doi.org/10.1093/eurpub/ckac030 PMID:35441219
  12. Sarich P, Cabasag CJ, Liebermann E, Vaneckova P, Carle C, Hughes S, et al. (2022). Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine. 47:101375. https://doi.org/10.1016/j.eclinm.2022.101375 PMID:35434579
  13. Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. (2022). The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 10(4):264–72. https://doi.org/10.1016/S2213-8587(22)00035-3 PMID:35271818
  14. Cabasag CJ, Arnold M, Rutherford M, Bardot A, Ferlay J, Morgan E, et al. (2022). Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. Br J Cancer. 126(12):1774–82. https://doi.org/10.1038/s41416-022-01752-3 PMID:35236937
  15. Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L (2022). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. Int J Cancer. 150(4):580–93. https://doi.org/10.1002/ijc.33826 PMID:34569617
  16. Bray F, Laversanne M, Cao B, Varghese C, Mikkelsen B, Weiderpass E, et al. (2021). Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4. Cancer Treat Rev. 100:102290. https://doi.org/10.1016/j.ctrv.2021.102290 PMID:34536729
  17. Soerjomataram I, Bardot A, Aitken J, Piñeros M, Znaor A, Steliarova-Foucher E, et al. (2022). Impact of the COVID-19 pandemic on population-based cancer registry. Int J Cancer. 150(2):273–8. https://doi.org/10.1002/ijc.33792 PMID:34480348
  18. Soerjomataram I, Ervik M, Fox C, Hawkins S, Yeung K, Napolitano G, et al. (2021). CanStaging+: an electronic staging tool for population-based cancer registries. Lancet Oncol. 22(8):1069. https://doi.org/10.1016/S1470-2045(21)00188-1 PMID:34339643
  19. Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, et al. (2021). Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 22(8):1071–80. https://doi.org/10.1016/S1470-2045(21)00279-5 PMID:34270924
  20. Soerjomataram I, Bray F (2021). Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 18(10):663–72. https://doi.org/10.1038/s41571-021-00514-z PMID:34079102


Close Reading Mode